Introduction
Autoimmune pancreatitis (AIP) is a unique form of chronic pancreatitis characterized by a high serum IgG4 concentration and complications involving a variety of extrapancreatic lesions. Various imaging findings show pancreatic swelling, irregular narrowing of the main pancreatic duct, and stenosis of the lower bile duct.
Histopathological examination shows extensive proliferation of lymphocytes, plasma cell infiltration, and fibrosis with infiltration of many IgG4-bearing plasma cells (1) . For the diagnosis of AIP, the Japan Pancreas Society proposed a revison of clinical criteria in 2006 (2) , but little is known about a possible direct association of AIP and pancreatic pseudocysts. AIP associated with hemorrhagic pseudocysts is rare. Herein, we present such a rare case.
Case report
In May 2007, a 63-year-old male was referred to our department for further examination because of liver dysfunction since 1997, although it was asymptomatic. He had no drinking habit and no personal or family history of liver or pancreatic disease.
The abdomen was soft; no mass was palpable. Laboratory data were as follows: total bilirubin (T. Bil), 0. Ultrasonography (US) demonstrated no swelling and no dilatation of the main pancreatic duct in the head or body of the pancreas. However, imaging the tail of the pancreas was impossible and dilatation of the intrahepatic bile duct was not found by US. Portal phase-enhanced computed tomography (CT) revealed swelling and a low contrast margin expressed as a capsule-like low-density rim in the tail of the pancreas associated with pancreatic cysts (Fig. 1A) . Endoscopic ultrasonography (EUS) showed hypoechoic pancreatic parenchyma with scattered high-echo spots in the enlarged area associated with pseudocysts in the tail of the pancreas (Fig. 1B) . Based on the clinical, laboratory and imaging findings, the patient was diagnosed as having chronic hepatitis and suspected of having AIP. Endoscopic retrograde cholangiopancreatography (ERCP) for the pancreatic lesion was not performed because informed consent was not obtained. occlusion of the main pancreatic duct in the tail of the pancreas (Fig. 3) . Gross appearance of the resected specimen was a white nodular mass, measuring 3.0×2.5 cm, with cystic lesions, measuring 4.5×3.0 cm at the greatest dimension. Imaging of the cut surface of the pancreatic tail showed whitish matter inside the dilated peripheral pancreatic duct, which was not detected preoperatively; the whitish matter was accumulated protein plaques (Fig. 4) .
Histopathological examination revealed significant lymphoplasmatic infiltration and fibrosis in the tail of the pancreas (Fig. 5A ). Immunohistochemistry revealed numerous IgG4-positive plasma cells that had inflated the pancreas (Zymed, Carlsbad, CA; dilution 1:500) (Fig. 5B ). The resected cysts had no epithelial cells (Fig. 5C ), and the inner surfaces were covered with fibrinohemorrhagic exudative tissue and granulation tissue. The postoperative course was uneventful and the patient was discharged after eight days. Two months after the operation, the serum IgG4 concentration was not lowered (1190 mg/dL); however, this symptom was not a reccurence. ERCP revealed normal findings of the main pancreatic duct in the residual pancreas and both intrahepatic and extrahepatic bile ducts. No complication of sclerosing sialadenitis, retroperitoneal fibrosis, orbital pseudocumor or Riedel's thyroiditis has been found to date, and the patient is under observation as an outpatient.
Discussion
We Studies have shown that non-neoplastic pancreatic cysts accompanying AIP include two types: retension cysts (3) and pseudocysts (4-11). Histopathological study has so far been carried out only on a limited number of surgically treated cases, and there has been no discussion on which type of cyst is more likely to develop. Further study of such cases is needed.
There have been only 8 cases of pseudocysts associated with AIP prior to the present case (Table 1 ) (4-11). Intracystic hemorrhage was reported in one of the 8 cases, but it was minor bleeding and spontaneously healed (5). Intraperitoneal rupture of hemorrhagic pseudocysts as in the present case has not been reported previously.
Corticosteroid treatment in AIP patients is clinically, morphologically, and serologically effective and has become accepted as a standard treatment for AIP.
Previous studies have shown that corticosteroid treatment is effective in AIP patients in the short term (11). Long-term prognoses for patients with AIP, including patients who received corticosteroid treatment, have recently been reported (9). It should be noted that corticosteroid treatment carries the risk of a variety of adverse effects, including susceptibility to infection, impaired glucose tolerance, peptic ulcer and osteoporosis.
Thus, it still remains to be determined whether corticosteroid treatment is necessary for all patients with AIP. In fact, conditions improve spontaneously in some AIP patients (12, 13) . Four cases of pseudocysts associated with AIP were treated with corticosteroid, and the pseudocysts disappeared in three of them.
Nishimura et al (6) suggeseted that the severe narrowing of the branched pancreatic ducts might be responsible for the regrowth of pseudocysts. Corticosteroid treatment possibly ameliorated the narrowing of the pancreatic duct and released pancreatic juice, which induced rapid resolution of pancreatic ducts; cyst formation in AIP patients might represent a highly active state of the inflammatory process. The pancreatogram findings and results of histological examination, the present case suggested an etiological mechanism similar to that proposed by Nishimura et al (6) . Since we did not perform ERCP at our initial attempt at diagnosis, because informed consent had not been obtained, we cannot exclude the possibility that we might have observed therapeutic effects of corticosteroid treatment if we had been able to make a definite diagnosis of AIP by performing ERCP and performed treatment. However, considering that the pancreatic duct was completely occluded and that protein plaques, histopathologically related to pancreatic stricture, were present, we speculate that chronic changes had been occurring in the pancreatic stricture, which were irreversible, and thus corticosteroid treatment would not have been effective, if applied at the operation.
Recently, Hirano et al (9) reported that a growing pancreatic pseudocyst developed in an AIP patient who did not receive corticosteroid treatment. On the other hand, Nakazawa et al (10) reported that a pancreatic cyst in an AIP patient spontaneously disappeared before corticosteroid treatment. In the present case, we have to give priority to surgical treatment since there was heavy hemorrhage within the cysts caused by rupture of fragile vessels due to enlargement of the cysts and intracystic hemorrhage.
Although indication for corticosteroid treatment for pseuodocysts in AIP is difficult, we suggest that corticosteroid treatment should be started immediately when a pseudocyst appears, accompanying AIP, because the pseudocyst does disappear with treatment (or at least there has been no report of pseudocyst enlargement after corticosteroid treatment).
Generally, corticosteroid treatment is indicated for AIP patients when they have obstructive jaundice due to stenosis of the bile duct or complications of autoimmune diseases that present abnormal symptoms or findings (14, 15) . Continuation of corticosteroid treatment is important for prevention of progression of the disease and other relevant diseases. However, the appropriate period of corticosteroid treatment and required continuity of corticosteroid administration remain to be determined (16) . 
